ARCHIVES

DCBD To Fund Diagnostic Clinical Trials By CCOPs, Cooperative Groups

This article is from The Cancer Letter archive.

Vol. 15 No. 26 | June 30, 1989

Download PDF Visit The Full Archive

Related Articles

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

Some Long-Term Survivors At Higher Risk Of Stroke

November 24, 2006

HCFA Sees Applications For DRGs And Research

September 27, 1985

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

May 20, 2005

UHC Expands Risk Models To Include 25 Cancer Variables

February 24, 2012

ORI Finds Misconduct By Two Researchers

December 8, 1995